TOPAS THERAPEUTICS
Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies. The Topas Particle Conjugates technology platform induces antigen-specific immune tolerance by harnessing the liver’s natural immunology capabilities. The Company has several proprietary programs; lead product candidate TPM203 has recently entered clinical testing for pemphigus v... ulgaris, an orphan disease. Other programs are in anti-drug antibodies, celiac disease, Type 1 diabetes, as well as a multiple sclerosis program that is available for partnering. Topas has a research and option agreement with Eli Lilly and Company focused on antigen-specific tolerance induction and a multi-year agreement with Boehringer Ingelheim to collaborate in the field of anti-drug antibodies. Topas’ investors include: Epidarex Capital, Gimv, EMBL Ventures, Evotec and Boehringer Ingelheim Venture Fund.
TOPAS THERAPEUTICS
Industry:
Advanced Materials Biotechnology Chemical Chemical Engineering
Founded:
2006-01-01
Address:
Hamburg, Hamburg, Germany
Country:
Germany
Website Url:
http://www.topas-therapeutics.com
Total Employee:
51+
Status:
Active
Contact:
+49 40 302089010
Total Funding:
58 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Current Employees Featured
Klaus Martin Chief Executive Officer @ Topas Therapeutics
Chief Executive Officer
2020-01-01
Cristina Min Chief Medical Officer @ Topas Therapeutics
Chief Medical Officer
2021-09-01
Timm-H. Jessen Co-Founder, Board Member and Chief Executive Office @ Topas Therapeutics
Co-Founder, Board Member and Chief Executive Office
Johannes Pohlner Co-Founder and Chief Operating Officer @ Topas Therapeutics
Co-Founder and Chief Operating Officer
Timothy Kneale President @ Topas Therapeutics
President
Founder
Investors List
Evotec
Evotec investment in Series B - Topas Therapeutics
Epidarex Capital
Epidarex Capital investment in Series B - Topas Therapeutics
EMBL Ventures
EMBL Ventures investment in Series B - Topas Therapeutics
Vesalius Biocapital Partners
Vesalius Biocapital Partners investment in Series B - Topas Therapeutics
BioMedPartners
BioMedPartners investment in Series B - Topas Therapeutics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series B - Topas Therapeutics
Gimv
Gimv investment in Series B - Topas Therapeutics
EMBL Ventures
EMBL Ventures investment in Series B - Topas Therapeutics
Vesalius Biocapital Partners
Vesalius Biocapital Partners investment in Series B - Topas Therapeutics
Gimv
Gimv investment in Series B - Topas Therapeutics
Newest Events participated
Participated in Pre-Filled Syringes East Coast 2017
on 2017-04-26 as sponsor
Participated in Pre-Filled Syringes East Coast 2017
on 2017-04-26 as exhibitor
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-15 | Topas Therapeutics Appoints Cristina de Min, M.D. as Chief Medical Officer |
Official Site Inspections
http://www.topas-therapeutics.com
- Host name: dd24006.kasserver.com
- IP address: 85.13.146.149
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Topas Therapeutics"
Topas Therapeutics – Transforming the field of …
Topas Therapeutics GmbH. Falkenried 88, Haus A 20251 Hamburg GERMANY +49 40 302089010 info@topas-therapeutics.comSee details»
Topas Therapeutics - Crunchbase Company Profile
Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet …See details»
Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief Executive ...
Oct 19, 2020 Topas Therapeutics GmbH. Falkenried 88, Haus A 20251 Hamburg GERMANY +49 40 302089010 info@topas-therapeutics.com. CONTACT. CONTACT. ... he was Chief …See details»
Topas Therapeutics - Contacts, Employees, Board Members
Organization. Topas Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. About. …See details»
Topas Therapeutics | Boehringer Ingelheim Venture Fund
Topas advances a versatile platform approach to establish immune tolerance in autoimmune and immune-mediated diseases. Topas is a clinical-stage biotech company, which develops a …See details»
Topas Therapeutics (Topas Therapeutics GmbH) - Startbase
Recent mentions of Topas Therapeutics in podcasts & videos: Jobs at Topas Therapeutics: Other Startups nearby. HR Puls. Startup 2012 Hamburg. HR Puls. Cloud based HR Software for …See details»
Topas Therapeutics Company Profile - Office Locations ... - Craft
Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as …See details»
Topas Therapeutics GmbH (TT) - Phoenix
Topas Therapeutics GmbH is a Germany-based and investor-funded biotech company located in Hamburg. Topas is utilizing its cutting-edge technology platform to develop a pipeline of novel therapies to treat autoimmune …See details»
Topas Therapeutics GmbH - VentureRadar
Topas Therapeutics is a clinical-stage biotechnology company with a mission to deliver novel, disease-modifying treatments for autoimmune and inflammatory diseases. At Topas we are …See details»
Topas Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Evotec spins off auto-immune disease company as 'Topas …
Mar 22, 2016 The new company, Topas Therapeutics GmbH ("Topas"), aims to build a unique pipeline of clinical-stage development projects to treat autoimmune diseases. The proceeds of …See details»
Topas Therapeutics GmbH - Drug pipelines, Patents, Clinical
Explore Topas Therapeutics GmbH with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 7 news, and 3 literature, Disease Domain:Immune System Diseases, …See details»
Topas Therapeutics (Topas Therapeutics GmbH) - Startbase
Die neusten Erwähnungen von Topas Therapeutics in Podcasts & Videos: Offene Jobs bei Topas Therapeutics: Weitere Startups in der Nähe von Topas Therapeutics. HR Puls. Startup 2012 …See details»
Topas Therapeutics - Portfolio Company Profile, Executives and …
See Topas Therapeutics's complete profile, including its private equity owner and the number of its executive contacts in our database. Topas Therapeutics developed a unique technology for …See details»
Evotec gründet Topas Therapeutics GmbH aus – ein Unternehmen ...
Info@topas-therapeutics.com Topas Therapeutics GmbH Falkenried 88, Haus B 20251 Hamburg (Germany) Evotec gründet Topas Therapeutics GmbH aus – ein Unternehmen spezialisiert …See details»
Topas particle conjugates coupled with tolerogenic peptide …
Topas Therapeutics is focused on developing Topas particle conjugates (TPCs), an antigen coupled nanoparticle platform technology, that target liver sinusoidal endothelial cells to …See details»
Pipeline - Topas Therapeutics
Topas Therapeutics GmbH. Falkenried 88, Haus A 20251 Hamburg GERMANY +49 40 302089010 info@topas-therapeutics.comSee details»
Topas Therapeutics Raises EUR 14 Million to Treat Immunological ...
Mar 22, 2016 Topas Therapeutics GmbH. Falkenried 88, Haus A 20251 Hamburg GERMANY +49 40 302089010 info@topas-therapeutics.com. CONTACT. CONTACT. CONTACT. HOME; …See details»
Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief
Hamburg, 19 October 2020: Topas Therapeutics GmbH (Topas), a Hamburg, Germany-based private platform company leveraging the natural immune tolerance induction capabilities of the …See details»
Topas claims success in early test of ‘immune tolerance’ celiac …
1 day ago Hugo Fry, Topas Therapeutics CEO. May 5, 2025 03:01 AM EDT Updated 06:18 AM. R&D. Exclusive: Topas claims success in early test of 'immune tolerance' therapy for celiac …See details»